Does ‘heparin-induced thrombocytopenia’ hit our minds?
| Autor: | Shalvi Mahajan, Arun Raja Thangavel, Amarjyoti Hazarika |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Deep vein Critical Care and Intensive Care Medicine Fondaparinux lcsh:RD78.3-87.3 Heparin-induced thrombocytopenia medicine In patient deep venous thrombosis business.industry fondaparinux Heparin Heparin prophylaxis unfractionated heparin medicine.disease Thrombosis Surgery Venous thrombosis Anesthesiology and Pain Medicine medicine.anatomical_structure lcsh:Anesthesiology Anesthesia Neurology (clinical) heparin-induced thrombocytopenia business medicine.drug |
| Zdroj: | Journal of Neuroanaesthesiology and Critical Care, Vol 03, Iss 03, Pp 245-248 (2016) |
| ISSN: | 2348-926X 2348-0548 |
| DOI: | 10.4103/2348-0548.190071 |
| Popis: | Unfractionated heparin is a widely used drug to prevent deep vein thrombosis and pulmonary emboli in patients at risk. With the advent of newer anticoagulants having lesser side effects, its use has diminished but not out of service. Here, we report a case of deep venous thrombosis, in a patient on prophylactic dose of heparin, which was later found to be a manifestation of heparin-induced thrombocytopenia (HIT). Thrombosis in the presence of heparin prophylaxis should be considered as HIT rather than a failure of anticoagulation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|